T2 Biosystems Statistics

Total Valuation

T2 Biosystems has a market cap or net worth of $8.63 million. The enterprise value is $25.79 million.

Market Cap	8.63M
Enterprise Value	25.79M

Important Dates

The next estimated earnings date is Thursday, February 13, 2025, after market close.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	n/a

Share Statistics

T2 Biosystems has 21.04 million shares outstanding. The number of shares has increased by 659.51% in one year.

Current Share Class	21.04M
Shares Outstanding	21.04M
Shares Change (YoY)	+659.51%
Shares Change (QoQ)	+26.94%
Owned by Insiders (%)	4.85%
Owned by Institutions (%)	7.18%
Float	7.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.47
Forward PS	0.45
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-84.85%
Return on Capital (ROIC)	-138.95%
Revenue Per Employee	$67,938
Profits Per Employee	-$380,124
Employee Count	113
Asset Turnover	0.25
Inventory Turnover	6.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.15% in the last 52 weeks. The beta is 0.35, so T2 Biosystems's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-92.15%
50-Day Moving Average	0.68
200-Day Moving Average	3.00
Relative Strength Index (RSI)	38.07
Average Volume (20 Days)	948,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T2 Biosystems had revenue of $7.68 million and -$42.95 million in losses. Loss per share was -$4.08.

Revenue	7.68M
Gross Profit	-19.03M
Operating Income	-41.66M
Pretax Income	-48.26M
Net Income	-42.95M
EBITDA	-41.40M
EBIT	-41.66M
Loss Per Share	-$4.08

Full Income Statement

Balance Sheet

The company has $2.08 million in cash and $18.94 million in debt, giving a net cash position of -$16.86 million or -$0.80 per share.

Cash & Cash Equivalents	2.08M
Total Debt	18.94M
Net Cash	-16.86M
Net Cash Per Share	-$0.80
Equity (Book Value)	-11.71M
Book Value Per Share	-0.62
Working Capital	-14.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.59 million and capital expenditures -$26,000, giving a free cash flow of -$36.62 million.

Operating Cash Flow	-36.59M
Capital Expenditures	-26,000
Free Cash Flow	-36.62M
FCF Per Share	-$1.74

Full Cash Flow Statement

Margins

Gross Margin	-247.83%
Operating Margin	-542.59%
Pretax Margin	-559.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

T2 Biosystems does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-659.51%
Shareholder Yield	-659.51%
Earnings Yield	-481.20%
FCF Yield	-410.22%

Analyst Forecast

The average price target for T2 Biosystems is $5.00, which is 1,119.51% higher than the current price. The consensus rating is "Hold".

Price Target	$5.00
Price Target Difference	1,119.51%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 13, 2023. It was a reverse split with a ratio of 0.01:1.

Last Split Date	Oct 13, 2023
Split Type	Reverse
Split Ratio	0.01:1

Scores

T2 Biosystems has an Altman Z-Score of -55.05 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-55.05
Piotroski F-Score	1